SEIA
ABBV icon

Signature Estate & Investment Advisors’s AbbVie ABBV Stock Holding History

Signature Estate & Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
5,312
-182
-3% -$39.2K 0.02% 220
2026
Q1 		$1.19M Buy
5,494
+93
+2% +$20.6K 0.02% 244
2025
Q4 		$1.23M Sell
5,401
-214
-4% -$48.7K 0.02% 227
2025
Q3 		$1.3M Sell
5,615
-257
-4% -$52.3K 0.03% 209
2025
Q2 		$1.09M Sell
5,872
-658
-10% -$122K 0.03% 222
2025
Q1 		$1.37M Buy
6,530
+316
+5% +$61.4K 0.04% 179
2024
Q4 		$1.1M Buy
6,214
+156
+3% +$28.7K 0.03% 198
2024
Q3 		$1.2M Buy
6,058
+40
+0.7% +$7.46K 0.03% 176
2024
Q2 		$1.03M Buy
6,018
+4,279
+246% +$709K 0.03% 192
2024
Q1 		$317K Buy
1,739
+150
+9% +$25.9K 0.01% 137
2023
Q4 		$246K Sell
1,589
-124
-7% -$18.1K 0.01% 163
2023
Q3 		$256K Sell
1,713
-17
-1% -$2.5K 0.01% 148
2023
Q2 		$233K Sell
1,730
-26
-1% -$3.81K 0.01% 163
2023
Q1 		$280K Sell
1,756
-116
-6% -$17.7K 0.01% 151
2022
Q4 		$303K Sell
1,872
-436
-19% -$66.9K 0.01% 149
2022
Q3 		$309K Sell
2,308
-100
-4% -$14.3K 0.01% 136
2022
Q2 		$368K Sell
2,408
-125
-5% -$19.1K 0.02% 124
2022
Q1 		$410K Buy
2,533
+311
+14% +$45.2K 0.02% 118
2021
Q4 		$301K Sell
2,222
-64
-3% -$7.56K 0.01% 143
2021
Q3 		$246K Sell
2,286
-336
-13% -$38.4K 0.01% 147
2021
Q2 		$296K Buy
2,622
+203
+8% +$22.9K 0.01% 136
2021
Q1 		$262K Buy
2,419
+250
+12% +$26.7K 0.01% 144
2020
Q4 		$232K Buy
+2,169
New +$208K 0.01% 144
2019
Q1 		– Sell
-1,634
Closed -$151K – 154
2018
Q4 		$151K Buy
1,634
+453
+38% +$39.8K 0.01% 154
2018
Q3 		$112K Buy
+1,181
New +$112K 0.01% 142
2017
Q2 		– Sell
-2,812
Closed -$183K – 144
2017
Q1 		$183K Buy
+2,812
New +$177K 0.02% 148

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Signature Estate & Investment Advisors's ABBV Position: Q2 2026 in Review

Signature Estate & Investment Advisors reduced its AbbVie (ABBV) stake by 3.3% in Q2 2026, selling an estimated $39.2K and leaving 5,312 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #220.

Signature Estate & Investment Advisors first reported a position in ABBV in Q1 2017 and has held it in 26 quarters since. The position peaked at $1.37M in Q1 2025. 2,901 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Signature Estate & Investment Advisors held 5,312 shares of AbbVie worth $1.34M as of Q2 2026.
  • Signature Estate & Investment Advisors sold 182 AbbVie shares in Q2 2026, an estimated $39.2K.
  • AbbVie made up 0.02% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #220 holding.
  • Signature Estate & Investment Advisors first reported a position in AbbVie in Q1 2017 and has held it in 26 quarters since.
  • Signature Estate & Investment Advisors's AbbVie position peaked at $1.37M in Q1 2025.
  • 2,901 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.